Vitamin E‐‐Bonded Cellulose Membrane, Lipoperoxidation, and Anemia in Hemodialysis Patients

Figures & data

Table 1. Hematological and biochemical parameters before and during dialisys treatment with vitamin E‐‐modified membrane

	t0	t3	t6	t12	P
Hemoglobin (g//dl)	10.3±0.4	10.4±0.6	10.2±0.3	10.2±0.5	NS
RBC (× 10^6//mmc)	3.25±0.36	3.35±0.32	3.24±0.46	3.29±0.40	NS
Hematocrit (%%)	32.7±1.6	33.4±1.4	32.9±1.8	32.9±1.7	NS
EPO (U//Kg//sett)	97.4±28.3	94.3±31.6	98.1±30.4	95.1±26.3	NS
Kt//V	1.22±0.14	1.18±0.09	1.26±0.12	1.27±0.18	NS
Ferritin (ng//mL)	342±144	332±126	294±163	309±174	NS
Tranferrin Sat. (%%)	36.3±3.2	33.8±4.3	30.2±5.3	31.4±5.1	NS

Table 2. Vitamin E and MDA levels before and during dialisys treatment with vitamin E‐‐modified membrane

	t0	t3	t6	t12	Control	P
Vitamin E (mg//L)	13.01±2.88	15.06±4.03	15.88±3.92	15.63±3.41	14.79±3.12	NS
MDA (nmol//mL)	1.87±0.36**	1.31±0.22	1.27±0.24	1.29±0.18	1.13±0.18**	** < 0.01

Figure 1. Malonyldialdehyde levels at baseline and during Excebrane® treatment.